ICYMI: China Committee Eyes Supply Chain, Biotech as Moolenaar Takes Helm

WASHINGTON DC — In case you missed it, Roll Call published a story this morning highlighting Chairman John Moolenaar's rise to lead the Select Committee on the Chinese Communist Party and his priorities as he takes the helm.

--

The House select committee on U.S.-China competition, freshly under new leadership, is training its sights on a range of tech, defense, economic and foreign policy issues on the heels of a major victory on the bill to force the divestiture of TikTok.

Mike Gallagher, R-Wis., last week left Congress and stepped down as chairman of the House Select Committee on the Strategic Competition between the United States and the Chinese Communist Party. His replacement as chair, Michigan Republican Rep. John Moolenaar, said in a statement on Monday that he will focus on preventing “the CCP from stealing our technology, co-opting businesses, and harassing people on American soil.” 

“We will examine the most critical areas of our supply chain so we can reduce our dependence on the CCP,” Moolenaar said...

[Ranking Member Raja] Krishnamoorthi said another measure championed by the committee that targets the practices of specific companies should be a “no-brainer bill.” The measure would ban federal research funds going to U.S. companies that in turn hire Chinese biotech companies, including MGI, Complete Genomics, WuXi AppTec, and BGI Group and its subsidiaries....

Virginia Republican Rep. Rob Wittman, who chairs the House Armed Services Subcommittee on Tactical Air and Land Forces, said in an interview that he considers the recommendations focused on deterring a Chinese invasion of Taiwan to be one of the select committee’s biggest accomplishments.

Continue reading the story in Roll Call HERE.